A carregar...

Pharmacoeconomic analysis of the anidulafungin (EraxisR) in adult patients with invasive candidiasis

Objective: to assess the economic outcomes of using anidulafungin (Eraxis®) in comparison with the recommended treatment regimens in adult patients with invasive candidiasis.Materials and methods. The economic impact assessment was carried out using “cost–effectiveness” analysis and “budget impact”...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: S. V. Nedogoda, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova
Formato: Artigo
Idioma:Russo
Publicado em: ABV-press 2019-10-01
Colecção:Onkogematologiâ
Assuntos:
Acesso em linha:https://oncohematology.abvpress.ru/ongm/article/view/375
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!